Research Director Dr. Pasi Korhonen’s presentation

28.8.2015 – Our Research Director Dr. Pasi Korhonen gave an oral presentation titled “Preliminary Results of Bladder Cancer Risk in Relation To Exposure To Pioglitazone Among Patients With T2DM in the Pan European Multi-Database Bladder Cancer Risk Characterisation Study” in the 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management in Boston, US on August 24, 2015. For further information, please see the abstract.